Ardelyx Inc. News
Ardelyx Plunges as FDA Questions Kidney Disorder Treatment Drug
Ardelyx shares plunge after the Food and Drug Administration identifies 'deficiencies' on the company’s application for its kidney disease fighting drug Tenapanor.
5 Top Stock Gainers for Thursday: Weingarten Realty, Dell, Nvidia
Weingarten Realty, Dell, Nvidia, GlaxoSmithKline and Ardelyx are five top stock gainers for Thursday.
Biotech premarket movers: Ardelyx, Acorda Therapeutics, Medicines Co.
Ardelyx, Acorda Therapeutics and Medicines Co. were among the premarket biotech movers on Wednesday.
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.
These 5 under-$10 biotech stocks are about to break out
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Insider Trading Alert - ARDX, CARA And ALXN Traded By Insiders
Stocks with insider trader activity include ARDX, CARA and ALXN
Treasury Yields Jump After Weak $43 Billion 2-Year Auction, Sliding Foreign Demand
The Treasury sold $43 billion in 2-year notes at a high yield of 4.29% - nearly a full percentage point above last month's auction levels.
Economist El-Erian Sees Strong Chance for Recession
But he thinks the Fed must keep raising interest rates to quell inflation. And he expects continued market volatility.
Pound Collapse Puts Dollar Parity, Emergency Bank of England Rate Hikes in Focus
Britain's new government said it will continue focusing on tax cuts and new borrowing to boost growth even as markets push the pound to a record low against the U.S. dollar.
What Happens to Your Credit Card When Interest Rates Rise
With interest rates soaring, credit card consumers may be in for a shock